-
6-FAM SE for Durable Molecular Labeling
2026-08-23
6-FAM SE combines amine-selective coupling with durable fluorescein-based detection for DNA, peptides, proteins, and engineered nanomedicine assays. This practical guide covers reaction setup, label-to-substrate optimization, purification, controls, and how to adapt the chemistry for tracking stimulus-responsive systems.
-
Pretomanid Targets Terminal Oxidases in Tuberculosis
2026-08-22
The reference study identifies the cytochrome bcc:aa3 and cytochrome bd oxidases as complementary respiratory targets of pretomanid, clarifying how this prodrug affects both replicating and antibiotic-tolerant Mycobacterium tuberculosis. Its combination experiments support rational regimens pairing pretomanid with terminal-oxidase inhibitors to increase bactericidal activity and reduce resistance emergence.
-
Pretomanid Targets Terminal Oxidases in Tuberculosis
2026-08-22
The reference study identifies the cytochrome bcc:aa3 and cytochrome bd terminal oxidases as coordinated respiratory targets of pretomanid, also known as PA-824. Its combination data provide a mechanistic rationale for pairing pretomanid with Q203 and ND-011992 to improve bactericidal activity and constrain resistance in replicating and non-replicating Mycobacterium tuberculosis.
-
SAL, EZH2, and Endothelial Dysfunction
2026-08-21
The reference study shows that salidroside protects HUVECs from H2O2-induced endothelial dysfunction through an EZH2-associated reduction in inflammatory signaling and altered autophagy markers. Its combination of functional assays, molecular docking, gene-expression analysis, and EZH2 knockdown provides a mechanistic framework while also highlighting the need for direct target-validation studies.
-
Endogenous H2S Deficiency in Diabetic Cardiomyopathy
2026-08-20
The reference study identifies reduced endogenous hydrogen sulfide production as a contributor to lipotoxic myocardial injury in diabetic cardiomyopathy and links this deficit to endoplasmic reticulum stress. Its combined patient, rat, and cardiomyocyte experiments suggest that restoring H2S or suppressing ER stress can reduce lipid accumulation and apoptosis, while also defining important limits for causal interpretation.
-
Live-Dead Bacterial Staining Kit: Assay Design
2026-08-20
The Live-Dead Bacterial Staining Kit enables membrane-based bacterial viability analysis with NucGreen dye and EthD-III. This guide shows how to interpret dual fluorescence in antibacterial nanomaterial studies, using Fe3O4@ZIF-8 as a practical assay-design example.
-
EZH2, EMT, and Breast Carcinoma Cell State
2026-08-19
This bioRxiv preprint identifies EZH2 as a repressor of mesenchymal gene programs that helps breast carcinoma cells remain toward the epithelial end of a reversible EMT spectrum. By combining TGF-β-induced EMT, pharmacological EZH2 inhibition, and analysis of human tumor samples, the study proposes a conserved PRC2 mechanism with implications for metastasis biology and cancer epigenetics research.
-
2X HyperFusion High-Fidelity Master Mix for CRISPR
2026-08-19
Use 2X HyperFusion High-Fidelity Master Mix to generate accurate, blunt-ended amplicons for CRISPR construct verification, edit genotyping, and cloning workflows. Its proofreading chemistry is especially useful when PCR errors could be mistaken for true sequence changes in translational cancer-immunology studies.
-
Hoechst 33342 for Live-Cell Nuclear Imaging
2026-08-18
Build reliable live-cell nuclear staining, fixed-cell imaging, and flow cytometry workflows with a cell-permeant Hoechst 33342 nuclear stain. The workflow is tailored to dermal fibroblast senescence studies, where nuclear segmentation and cell counts complement mitochondrial, senescence, and extracellular-matrix readouts.
-
Oral Dextran Microgels for Local Colon Cancer Therapy
2026-08-18
The reference study develops a sequentially targeted oral system that combines dextran microgels with cisplatin- and SPION-loaded lipid nanoparticles for localized colon cancer treatment. Its design uses colon-associated enzymatic degradation, folate-receptor recognition, and alternating magnetic field activation to coordinate drug release, cellular uptake, chemotherapy, and magnetothermal therapy while potentially limiting systemic exposure.
-
Fluo-4 AM for Podocyte Calcium Signaling Assays
2026-08-17
Fluo-4 AM provides a bright, cell-permeant readout for real-time intracellular calcium dynamics, making it useful for podocyte signaling and high-throughput functional assays. This guide translates the GPR107 diabetic nephropathy findings into practical calcium-imaging workflows, assay controls, and troubleshooting decisions.
-
IR-1061 H-Aggregation for NIR-II Cancer Therapy
2026-08-17
Yu et al. developed RRIALP-C4, an anionic liposome that co-delivers IR-1061 and carboplatin while using RR9-mediated membrane fusion to transfer H-aggregated fluorophore into tumor cell membranes. The resulting platform combines NIR-II fluorescence imaging with NIR-I photothermal therapy and temperature-sensitive chemotherapy release, providing a formulation-level strategy for image-guided synergistic cancer treatment.
-
Lyso-Tracker Red for Reliable Live-Cell Assays
2026-08-16
Learn how Lyso-Tracker Red, SKU B8814, can resolve common interpretation and workflow problems in cell viability, proliferation, and cytotoxicity studies. This scenario-based guide covers live-cell compatibility, protocol control, fluorescence interpretation, and practical vendor selection.
-
Betaine Hydrochloride for Inflammation Assays
2026-08-15
Learn how to use Betaine hydrochloride as a controlled matrix variable, enzyme-assay reagent, and exploratory cell culture supplement when building inflammation-focused workflows. The guide connects practical reagent handling with the TLR4/NF-κB/NLRP3 findings reported in esophageal cancer research without overstating what the compound has been shown to do.
-
Mitoxantrone HCl: From Mechanism to Assay Design
2026-08-14
Mitoxantrone HCl is a DNA topoisomerase II inhibitor with applications that extend from DNA-damage biology to estrogen-receptor degradation. This guide translates its dual mechanisms into practical assay decisions for leukemia, stem-cell, multiple sclerosis, and pancreatic cancer research.